Kimberly-Clark announced Monday morning that it agreed to buy Tylenol maker Kenvue for $48.7 billion, making the newly combined company one of the largest in the consumer health space.

Executives said the acquisition created a new “global health and wellness leader” able to generate up to $32 billion in annual revenue. The manufacturer of Tylenol has now joined the owner of brands such as Kleenex tissues and Huggies diapers.

Recommended Stories

China and other global rivals are diversifying their energy portfolios away from coal

The Democrats' government shutdown has turned staff into indentured servants. Will the party set them free?

NRA announces restructuring of media department to prepare for 'fights ahead'

In a press release , Kimberly-Clark Chairman and CEO Mike Hsu said

See Full Page